Integral Diagnostics Limited (IDX.AX)
ASX · AUD · Healthcare · Diagnostics & Research
A$2.13 (+1.91%) as of
Key statistics
- Market cap
- 795.97M
- P/E (TTM)
- 35.50
- Forward P/E
- 13.71
- EPS (TTM)
- 0.0600
- Dividend yield
- 4.45%
- 52-week range
- 1.9050 – 2.7100
- Beta
- 0.18
- Revenue (TTM)
- 788.62M
- Profit margin
- 2.78%
- Analyst target
- A$2.99
- Volume
- 777.93k
About Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- East Melbourne, VIC, Australia
- Employees
- 3,049
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.